Join the Atopic Dermatitis group to help and get support from people like you.
Atopic Dermatitis News
Related terms: Atopic Eczema, Dermatitis, Atopic, Discoid Eczema, Infantile Eczema
Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis Risk
WEDNESDAY, May 8, 2024 – Systemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis (AD) risk in a dose-response fashion, according to a study published...
Stigma Affects Quality of Life in Children With Chronic Skin Conditions
TUESDAY, April 30, 2024 – Health care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases,...
Atopic Dermatitis Negatively Impacts Mental Health
TUESDAY, April 23, 2024 – Atopic dermatitis (AD) negatively impacts patients’ mental health (MH), especially when a patient has severe AD, according to a study published online March 14 i...
AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis
MONDAY, March 18, 2024 – Lebrikizumab demonstrates improvement in skin clearance and itch relief in patients with skin of color and moderate-to-severe atopic dermatitis, according to a study...
Atopic Dermatitis in Children Tied to Learning, Memory Difficulties
TUESDAY, March 12, 2024 – Pediatric atopic dermatitis (AD) is associated with greater odds of reported difficulties in learning and memory, but this association is driven by children with ...
AAD: Concerns Noted Relating to Use of AI Dermatology Apps
FRIDAY, March 8, 2024 – There are notable concerns relating to the use of currently available artificial intelligence (AI) dermatology mobile applications (apps), according to a study published...
Climatic Hazards Linked to Aggravation of Atopic Dermatitis
WEDNESDAY, Jan. 24, 2024 – Climatic hazards are likely to aggravate atopic dermatitis (AD), with the impact including direct and indirect effects, according to a review published online Jan. 24 in...
Dupixent (dupilumab) U.S. Label Updated with Data Further Supporting Use in Atopic Dermatitis with Moderate-to-Severe Hand and Foot Involvement
TARRYTOWN, N.Y. and PARIS, Jan. 16, 2024 (GLOBE NEWSWIRE) – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has updated the...
Skin Clinic Visits Increased With High Carbon Monoxide Levels Due to Wildfires
WEDNESDAY, Jan. 3, 2024 – An increase in carbon monoxide (CO) levels associated with the Canadian wildfires of 2023 correlated with increased atopic dermatitis (AD), dermatitis, and eczema-related...
LEO Pharma Inc. Announces U.S. FDA Approval of Adbry (tralokinumab-ldrm) for the Treatment of Moderate-to-Severe Atopic Dermatitis in Pediatric Patients Aged 12-17 Years
Adbry is the first treatment for pediatric patients with moderate-to-severe atopic dermatitis specifically targeting the interleukin (IL)-13 cytokine, one of the key drivers of atopic dermatitis...
Updated Guidelines Released for Management of Atopic Dermatitis
THURSDAY, Dec. 28, 2023 – In updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in...
Recommendations Developed for Atopic Dermatitis Therapies
THURSDAY, Nov. 16, 2023 – In updated guidelines issued by the American Academy of Dermatology and published online Nov. 7 in the Journal of the American Academy of Dermatology, recommendations are...
Teens With Atopic Dermatitis More Likely to Experience Bullying
FRIDAY, Oct. 27, 2023 – Adolescents with versus those without atopic dermatitis (AD) have increased prevalence and frequency of experiencing bullying, according to a study published online Oct. 25...
Children With Eczema More Likely to Have Allergic Contact Dermatitis
MONDAY, Oct. 2, 2023 – Children with atopic dermatitis (AD) are more likely to have positive patch test (PPT) reactions, according to a study published online Sept. 25 in the Journal of the American...
Both Ciclosporin, Methotrexate Effective for Severe Eczema in Children
TUESDAY, Sept. 26, 2023 – For children and young people with severe atopic dermatitis (AD), ciclosporin (CyA) and methotrexate (MTX) are both effective over 36 weeks, according to a study published...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
prednisone, methylprednisolone, clobetasol, fluocinonide, Dupixent, dexamethasone, desonide, halobetasol